Patents by Inventor Olivier Alexis Georges Querolle

Olivier Alexis Georges Querolle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW COMPOUNDS
    Publication number: 20160213677
    Abstract: The invention relates to new pyridopyrazine and naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: January 19, 2016
    Publication date: July 28, 2016
    Applicant: ASTEX THERAPEUTICS LIMITED
    Inventors: Patrick René ANGIBAUD, Isabelle Noëlle Constance PILATTE, Olivier Alexis Georges QUEROLLE
  • Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
    Patent number: 9309242
    Abstract: The invention relates to new pyridopyrazine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: April 12, 2016
    Assignee: ASTEX THERAPEUTICS LTD
    Inventors: Valerio Berdini, Gordon Saxty, Patrick Rene Angibaud, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet, Bruno Roux, Lieven Meerpoel
  • Compounds
    Patent number: 9303030
    Abstract: The invention relates to new pyridopyrazine and naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: April 5, 2016
    Assignee: ASTEX THERAPEUTICS LIMITED
    Inventors: Patrick René Angibaud, Isabelle Noëlle Constance Pilatte, Olivier Alexis Georges Querolle
  • Substituted quinoxalines as FGFR kinase inhibitors
    Patent number: 9303029
    Abstract: The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: April 5, 2016
    Assignee: ASTEX THERAPEUTICS LTD
    Inventors: Steven John Woodhead, Christopher William Murray, Valerio Berdini, Gordon Saxty, Gilbert Ebai Besong, Lieven Meerpoel, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet
  • QUINAZOLINONE DERIVATIVES USEFUL AS FGFR KINASE MODULATORS
    Publication number: 20160075666
    Abstract: The invention relates to new quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: April 25, 2014
    Publication date: March 17, 2016
    Applicant: Astex Therapeutics Limited
    Inventors: Patrick René ANGIBAUD, Olivier Alexis Georges QUEROLLE, Isabelle Noëlle Constance PILATTE, Lieven MEERPOEL, Virginie Sophie PONCELET
  • PTERIDINES AS FGFR INHIBITORS
    Publication number: 20150291589
    Abstract: The invention relates to new pteridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: May 30, 2013
    Publication date: October 15, 2015
    Applicant: ASTEX THERAPEUTICS LIMITED
    Inventors: Gordon Saxty, Christopher Charles Frederick Hamlett, Valerio Berdini, Christopher William Murray, Patrick René Angibaud, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet
  • NEW COMPOUNDS
    Publication number: 20150239883
    Abstract: The invention relates to new pyridopyrazine and naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: May 30, 2013
    Publication date: August 27, 2015
    Applicant: ASTEX THERAPEUTICS LIMITED
    Inventors: Patrick René Angibaud, Isabelle Noëlle Constance Pilatte, Olivier Alexis Georges Querolle
  • ANTICANCER BENZOPYRAZINES VIA THE INHIBITION OF FGFR KINASES
    Publication number: 20150031669
    Abstract: The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: October 26, 2012
    Publication date: January 29, 2015
    Applicant: ASTEX THERAPEUTICS LIMITED
    Inventors: Steven John Woodhead, Christopher William Murray, Valerio Berdini, Gordon Saxty, Gilbert Ebai Besong, Lieven Meerpoel, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet
  • ANTICANCER PYRIDOPYRAZINES VIA THE INHIBITION OF FGFR KINASES
    Publication number: 20140288053
    Abstract: The invention relates to new pyridopyrazine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: October 26, 2012
    Publication date: September 25, 2014
    Applicant: ASTEX THERAPEUTICS LIMITED
    Inventors: Valerio Berdini, Gordon Saxty, Patrick Rene Angibaud, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet, Bruno Roux, Lieven Meerpoel